FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893706454> ?p ?o ?g. }

• W2893706454 endingPage "1644" @default.
• W2893706454 startingPage "1635" @default.
• W2893706454 abstract "This study aimed to investigate the HIV and hepatitis B virus (HBV) co-infection in three HIV high endemic areas with different modes of HIV transmission and explore the HBV nucleos(t)ide analogue resistance (NUCr) substitutions in this cohort receiving antiretroviral therapy (ART).The enrolled 705 HIV-infected patients were from three different regions in China and received lamivudine-based ART for at least 1 year. After screening for hepatitis B surface antigen (HBsAg), the hepatitis B e antigen (HBeAg), and antibody against hepatitis B core antigen (anti-HBc and anti-HBc IgM), HBV DNA in plasma of patients positive for HBsAg was tested. The reverse transcriptase (RT) sequences of HBV were analyzed by direct sequencing.The overall HBsAg-positive rate was 7.1% (50/705) (Guangxi [25/170, 14.7%], Xinjiang [13/257, 5.1%], and Henan [12/278, 4.3%]). The age, transmission route, and ethnic status were found to be associated with HIV/HBV co-infection. We obtained 23 HBV RT sequences belonging to genotypes B (9/23, 39.1%), C (13/23, 56.5%), and D (1/23, 4.4%). About 65.2% (15/23) of RT sequences harbored NUCr substitutions, all of which had combination substitution patterns. Patients with HBV NUCr had significantly higher HBV DNA level and ratio of HBeAg-positive than those without NUCr. None of the patients was found to have both lamivudine-resistant HBV and HIV.Our results suggested that HBsAg-positive rate in the studied patients was similar to that of the general population in each of the studied regions, where the age, transmission route, and ethnic status might also play roles in HIV/HBV co-infection. The HBV combination NUCr substitutions were common in co-infected patients under ART. Monitoring of HBV infection and NUCr substitutions in HIV-infected patients would help in providing better clinical decisions and management, thus lowering patients' risks to develop end-stage liver diseases." @default.
• W2893706454 created "2018-10-05" @default.
• W2893706454 creator A5003759585 @default.
• W2893706454 creator A5004196857 @default.
• W2893706454 creator A5006901857 @default.
• W2893706454 creator A5007678262 @default.
• W2893706454 creator A5026053703 @default.
• W2893706454 creator A5038935592 @default.
• W2893706454 creator A5056995229 @default.
• W2893706454 creator A5071931643 @default.
• W2893706454 creator A5080125444 @default.
• W2893706454 creator A5081590786 @default.
• W2893706454 creator A5088996114 @default.
• W2893706454 date "2018-10-01" @default.
• W2893706454 modified "2023-09-25" @default.
• W2893706454 title "Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China" @default.
• W2893706454 cites W1626038553 @default.
• W2893706454 cites W1971653018 @default.
• W2893706454 cites W1987841849 @default.
• W2893706454 cites W2006424422 @default.
• W2893706454 cites W2016449892 @default.
• W2893706454 cites W2042565956 @default.
• W2893706454 cites W2044661401 @default.
• W2893706454 cites W2048966750 @default.
• W2893706454 cites W2053214484 @default.
• W2893706454 cites W2062290173 @default.
• W2893706454 cites W2062368700 @default.
• W2893706454 cites W2079940253 @default.
• W2893706454 cites W2088354185 @default.
• W2893706454 cites W2141683526 @default.
• W2893706454 cites W2143403443 @default.
• W2893706454 cites W2151604374 @default.
• W2893706454 cites W2164067136 @default.
• W2893706454 cites W2168268029 @default.
• W2893706454 cites W2173698250 @default.
• W2893706454 cites W2174723704 @default.
• W2893706454 cites W2312049846 @default.
• W2893706454 cites W2313890354 @default.
• W2893706454 cites W2315876672 @default.
• W2893706454 cites W2324180581 @default.
• W2893706454 cites W2398023310 @default.
• W2893706454 cites W2586854864 @default.
• W2893706454 cites W2605785536 @default.
• W2893706454 cites W2741463176 @default.
• W2893706454 cites W2753050457 @default.
• W2893706454 cites W2791745392 @default.
• W2893706454 cites W2801666689 @default.
• W2893706454 doi "https://doi.org/10.2147/idr.s173757" @default.
• W2893706454 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6173268" @default.
• W2893706454 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30323633" @default.
• W2893706454 hasPublicationYear "2018" @default.
• W2893706454 type Work @default.
• W2893706454 sameAs 2893706454 @default.
• W2893706454 citedByCount "2" @default.
• W2893706454 countsByYear W28937064542021 @default.
• W2893706454 countsByYear W28937064542023 @default.
• W2893706454 crossrefType "journal-article" @default.
• W2893706454 hasAuthorship W2893706454A5003759585 @default.
• W2893706454 hasAuthorship W2893706454A5004196857 @default.
• W2893706454 hasAuthorship W2893706454A5006901857 @default.
• W2893706454 hasAuthorship W2893706454A5007678262 @default.
• W2893706454 hasAuthorship W2893706454A5026053703 @default.
• W2893706454 hasAuthorship W2893706454A5038935592 @default.
• W2893706454 hasAuthorship W2893706454A5056995229 @default.
• W2893706454 hasAuthorship W2893706454A5071931643 @default.
• W2893706454 hasAuthorship W2893706454A5080125444 @default.
• W2893706454 hasAuthorship W2893706454A5081590786 @default.
• W2893706454 hasAuthorship W2893706454A5088996114 @default.
• W2893706454 hasBestOaLocation W28937064541 @default.
• W2893706454 hasConcept C119599485 @default.
• W2893706454 hasConcept C127413603 @default.
• W2893706454 hasConcept C147483822 @default.
• W2893706454 hasConcept C159047783 @default.
• W2893706454 hasConcept C159654299 @default.
• W2893706454 hasConcept C203014093 @default.
• W2893706454 hasConcept C2522874641 @default.
• W2893706454 hasConcept C2775940106 @default.
• W2893706454 hasConcept C2777382497 @default.
• W2893706454 hasConcept C2777410769 @default.
• W2893706454 hasConcept C2777869810 @default.
• W2893706454 hasConcept C2780593183 @default.
• W2893706454 hasConcept C2908647359 @default.
• W2893706454 hasConcept C71924100 @default.
• W2893706454 hasConcept C761482 @default.
• W2893706454 hasConcept C99454951 @default.
• W2893706454 hasConceptScore W2893706454C119599485 @default.
• W2893706454 hasConceptScore W2893706454C127413603 @default.
• W2893706454 hasConceptScore W2893706454C147483822 @default.
• W2893706454 hasConceptScore W2893706454C159047783 @default.
• W2893706454 hasConceptScore W2893706454C159654299 @default.
• W2893706454 hasConceptScore W2893706454C203014093 @default.
• W2893706454 hasConceptScore W2893706454C2522874641 @default.
• W2893706454 hasConceptScore W2893706454C2775940106 @default.
• W2893706454 hasConceptScore W2893706454C2777382497 @default.
• W2893706454 hasConceptScore W2893706454C2777410769 @default.
• W2893706454 hasConceptScore W2893706454C2777869810 @default.
• W2893706454 hasConceptScore W2893706454C2780593183 @default.
• W2893706454 hasConceptScore W2893706454C2908647359 @default.

• next